Identification of flavonolignans from Silybum marianum seeds as allosteric protein tyrosine phosphatase 1B inhibitors

References

• Brown-Shimer S, Johnson KA, Lawrence JB, et al. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci USA 1990;87:5148–52.
   PubMed Web of Science ®Google Scholar
• Kennedy BP. Role of protein tyrosine phosphatase-1B in diabetes and obesity. Biomed Pharmacother 1999;53:466–70.
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000;20:5479–89.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang ZY. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today 2007;12:373–81.
   PubMed Web of Science ®Google Scholar
• Bentires AM, Neel BG. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res 2007;67:2420–4.
   PubMed Web of Science ®Google Scholar
• Erbe DV, Wang S, Zhang YL, et al. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Mol Pharmacol 2005;67:69–77.
   PubMed Web of Science ®Google Scholar
• Lantz KA, Hart SG, Planey SL, et al. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity (Silver Spring) 2010;18:1516–23.
   PubMed Web of Science ®Google Scholar
• He RJ, Yu ZH, Zhang RY, Zhang ZY. Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin 2014;35:1227–46.
   PubMed Web of Science ®Google Scholar
• Combs AP. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. J Med Chem 2010;53:2333–44.
   PubMed Web of Science ®Google Scholar
• Biagi M, Pecorari R, Appendino G, et al. Herbal products in Italy: the thin line between phytotherapy, nutrition and parapharmaceuticals; a normative overview of the fastest growing market in Europe. Pharmaceuticals 2016;9:65–74.
   Web of Science ®Google Scholar
• Hackett ES, Twedt DC, Gustafson DL. Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease. J Vet Intern Med 2013;27:10–6.
   PubMed Web of Science ®Google Scholar
• Schümann J, Prockl J, Kiemer AK, et al. Silibinin protects mice from T cell-dependent liver injury. J Hepatol 2003;39:333–40.
   PubMed Web of Science ®Google Scholar
• Trappoliere M, Caligiuri A, Schmid M, et al. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol 2009;50:1102–11.
   PubMed Web of Science ®Google Scholar
• Pferschy-Wenzig EM, Atanasov AG, Malainer C, et al. Identification of isosilybin A from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma. J Nat Prod 2014;77:842–7.
   PubMed Web of Science ®Google Scholar
• Voroneanu L, Nistor I, Dumea R, et al. Silymarin in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Res 2016;2016:1.
   Web of Science ®Google Scholar
• Soto C, Raya L, Juárez J, et al. Effect of silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model. Phytomedicine 2014;21:233–9.
   PubMed Web of Science ®Google Scholar
• Ebrahimpour koujan S, Gargari BP, Mobasseri M, et al. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine 2015;22:290–6.
   PubMed Web of Science ®Google Scholar
• Onoda T, Li W, Sasaki T, et al. Identification and evaluation of magnolol and chrysophanol as the principle protein tyrosine phosphatase-1B inhibitory compounds in a Kampo medicine, Masiningan. J Ethnopharmacol 2016;186:84–90.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Li W, Higai K, Koike K. Canthinone alkaloids are novel protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 2015;25:1979–81.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Li W, Higai K, et al. Protein tyrosine phosphatase 1B inhibitory activity of lavandulyl flavonoids from roots of Sophora flavescens. Planta Med 2014;80:557–60.
   PubMed Web of Science ®Google Scholar
• Li W, Li S, Higai K, et al. Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 2013;23:5836–9.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Li W, Morimura H, et al. Chemical constituents from Sambucus adnata and their protein-tyrosine phosphatase 1B inhibitory activities. Chem Pharm Bull 2011;59:1396–9.
   PubMed Web of Science ®Google Scholar
• Lee DYW, Liu Y. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from Silybum marianum (milk thistle). J Nat Prod 2003;66:1171–4.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang X, Wei P, et al. Chemical constituents from Inula wissmanniana and their anti-inflammatory activities. Arch Pharm Res 2013;36:1516–24.
   PubMed Web of Science ®Google Scholar
• Kim NC, Graf TN, Sparacino CM, et al. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Org Biomol Chem 2003;1:1684–9.
   PubMed Web of Science ®Google Scholar
• Pyszková M, Biler M, Biedermann D, et al. Flavonolignan 2, 3-dehydroderivatives: preparation, antiradical and cytoprotective activity. Free Radic Biol Med 2016;90:114–25.
   PubMed Web of Science ®Google Scholar
• MacKinnon SL, Hodder M, Craft C, Simmons-Boyce J. Silyamandin, a new flavonolignan isolated from milk thistle tinctures. Planta Med 2007;73:1214–6.
   PubMed Web of Science ®Google Scholar
• Wiesmann C, Barr KJ, Kung J, et al. Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 2004;11:730–7.
   PubMed Web of Science ®Google Scholar
• Tabernero L, Aricescu AR, Jones EY, Szedlacsek SE. Protein tyrosine phosphatases: structure-function relationships. FEBS J 2008;275:867–82.
   PubMed Web of Science ®Google Scholar
• Guigas B, Naboulsi R, Villanueva GR, et al. The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perifused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase. Cell Physiol Biochem 2007;20:925–34.
   PubMed Web of Science ®Google Scholar